GMED Relative Valuation
GMED's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GMED is overvalued; if below, it's undervalued.
Historical Valuation
Globus Medical Inc (GMED) is now in the Fair zone, suggesting that its current forward PE ratio of 21.80 is considered Fairly compared with the five-year average of 26.34. The fair price of Globus Medical Inc (GMED) is between 87.20 to 130.33 according to relative valuation methord.
Relative Value
Fair Zone
87.20-130.33
Current Price：87.75
Fair
22.05
PE
1Y
3Y
5Y
Trailing
Forward
11.79
EV/EBITDA
Globus Medical Inc. (GMED) has a current EV/EBITDA of 11.79. The 5-year average EV/EBITDA is 13.42. The thresholds are as follows: Strongly Undervalued below 5.79, Undervalued between 5.79 and 9.60, Fairly Valued between 17.23 and 9.60, Overvalued between 17.23 and 21.04, and Strongly Overvalued above 21.04. The current Forward EV/EBITDA of 11.79 falls within the Historic Trend Line -Fairly Valued range.
18.36
EV/EBIT
Globus Medical Inc. (GMED) has a current EV/EBIT of 18.36. The 5-year average EV/EBIT is 20.72. The thresholds are as follows: Strongly Undervalued below 10.43, Undervalued between 10.43 and 15.57, Fairly Valued between 25.87 and 15.57, Overvalued between 25.87 and 31.01, and Strongly Overvalued above 31.01. The current Forward EV/EBIT of 18.36 falls within the Historic Trend Line -Fairly Valued range.
3.82
PS
Globus Medical Inc. (GMED) has a current PS of 3.82. The 5-year average PS is 4.88. The thresholds are as follows: Strongly Undervalued below 1.19, Undervalued between 1.19 and 3.04, Fairly Valued between 6.72 and 3.04, Overvalued between 6.72 and 8.57, and Strongly Overvalued above 8.57. The current Forward PS of 3.82 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Globus Medical Inc. (GMED) has a current P/OCF of 0.00. The 5-year average P/OCF is 15.03. The thresholds are as follows: Strongly Undervalued below -12.55, Undervalued between -12.55 and 1.24, Fairly Valued between 28.82 and 1.24, Overvalued between 28.82 and 42.61, and Strongly Overvalued above 42.61. The current Forward P/OCF of 0.00 falls within the Undervalued range.
70.27
P/FCF
Globus Medical Inc. (GMED) has a current P/FCF of 70.27. The 5-year average P/FCF is 41.31. The thresholds are as follows: Strongly Undervalued below -47.35, Undervalued between -47.35 and -3.02, Fairly Valued between 85.64 and -3.02, Overvalued between 85.64 and 129.96, and Strongly Overvalued above 129.96. The current Forward P/FCF of 70.27 falls within the Historic Trend Line -Fairly Valued range.
Globus Medical Inc (GMED) has a current Price-to-Book (P/B) ratio of 2.69. Compared to its 3-year average P/B ratio of 2.44 , the current P/B ratio is approximately 9.85% higher. Relative to its 5-year average P/B ratio of 3.13, the current P/B ratio is about -14.26% higher. Globus Medical Inc (GMED) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.99%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.82% , the current FCF yield is about -100.00% lower.
2.72
P/B
Median3y
2.44
Median5y
3.13
4.94
FCF Yield
Median3y
2.99
Median5y
2.82
Competitors Valuation Multiple
The average P/S ratio for GMED's competitors is 2.21, providing a benchmark for relative valuation. Globus Medical Inc Corp (GMED) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 22.91%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GMED increased by 7.29% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 8.28 to 15.47.
The secondary factor is the Revenue Growth, contributed 22.91%to the performance.
Overall, the performance of GMED in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Globus Medical Inc (GMED) currently overvalued or undervalued?
What is Globus Medical Inc (GMED) fair value?
How does GMED's valuation metrics compare to the industry average?
What is the current P/B ratio for Globus Medical Inc (GMED) as of Dec 05 2025?
What is the current FCF Yield for Globus Medical Inc (GMED) as of Dec 05 2025?
What is the current Forward P/E ratio for Globus Medical Inc (GMED) as of Dec 05 2025?